BTC $66,608.67 +1.90%
ETH $1,935.15 +1.37%
BNB $574.29 +0.36%
XRP $1.12 +2.79%
SOL $78.39 +0.50%
TRX $0.3292 +0.90%
DOGE $0.0737 +2.16%
ADA $0.1734 +1.74%
BCH $223.84 +1.47%
LINK $8.69 +1.14%
HYPE $61.03 -2.31%
AAVE $95.79 +6.21%
SUI $0.7724 +0.86%
XLM $0.1931 +2.70%
ZEC $535.91 -1.77%
BTC $66,608.67 +1.90%
ETH $1,935.15 +1.37%
BNB $574.29 +0.36%
XRP $1.12 +2.79%
SOL $78.39 +0.50%
TRX $0.3292 +0.90%
DOGE $0.0737 +2.16%
ADA $0.1734 +1.74%
BCH $223.84 +1.47%
LINK $8.69 +1.14%
HYPE $61.03 -2.31%
AAVE $95.79 +6.21%
SUI $0.7724 +0.86%
XLM $0.1931 +2.70%
ZEC $535.91 -1.77%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41
Collection

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.